Skip to main content
UploadLanguage (EN)Support
BusinessMobileSocial MediaMarketingTechnologyArt & PhotosCareerDesignEducationPresentations & Public SpeakingGovernment & NonprofitHealthcareInternetLawLeadership & ManagementAutomotiveEngineeringSoftwareRecruiting & HRRetailSalesServicesScienceSmall Business & EntrepreneurshipFoodEnvironmentEconomy & FinanceData & AnalyticsInvestor RelationsSportsSpiritualNews & PoliticsTravelSelf ImprovementReal EstateEntertainment & HumorHealth & MedicineDevices & HardwareLifestyle
MedicoseAcademics, profile picture
Uploaded byMedicoseAcademics
18 views

Neuromascular Junction, Physiological Anatomy and Transmission

🧠 Explore Neuromuscular Junction Physiology with Dr Faiza 🧠 Understand how a motor nerve communicates with skeletal muscle and converts a nerve impulse into muscle contraction. This lecture explains the structure of the neuromuscular junction, acetylcholine synthesis and release, end plate potential, muscle action potential generation, excitation-contraction coupling, and major clinical disorders such as myasthenia gravis and Lambert-Eaton myasthenic syndrome. It is designed to support concept building, clinical understanding, and preparation for undergraduate, postgraduate, and licensing examinations including USMLE, PLAB, FCPS, NEET PG, and similar exams worldwide. 🎓 Speaker 🎓 Dr Faiza is a physiology educator with qualifications including MBBS as Best Graduate from Allama Iqbal Medical College, FCPS Physiology, MHPE from Riphah International University Islamabad, ICMT, CHPE, DHPE from STMU, MPH from Government College University Faisalabad, and MBA from Virtual University of Pakistan. Her academic expertise includes medical physiology, neurophysiology, muscle physiology, and health professions education. 🎯 Learning Objectives 🎯 Describe the structure of the neuromuscular junction and motor end plate. Explain the organization of the synaptic cleft and junctional folds. Describe the structure and function of nicotinic acetylcholine receptors. Explain the synthesis, storage, release, action, and breakdown of acetylcholine. Describe the ionic basis of the end plate potential. Explain how an end plate potential generates a muscle action potential. Describe the sequence of transmission across the neuromuscular junction. Explain the role of T tubules in excitation-contraction coupling. Discuss the safety factor and fatigue of the neuromuscular junction. Explain the mechanisms of drugs and toxins acting at the neuromuscular junction. Describe the pathophysiology, clinical features, diagnosis, and treatment of myasthenia gravis. Differentiate myasthenia gravis from Lambert-Eaton myasthenic syndrome. 🔬 Topics Covered 🔬 Neuromuscular junction Motor end plate Synaptic gutter and synaptic cleft Subneural and junctional folds Presynaptic nerve terminal Synaptic vesicles and dense bars Nicotinic acetylcholine receptor Fetal and adult acetylcholine receptor subunits Acetylcholine-gated cation channels End plate potential Generation of skeletal muscle action potential Acetylcholine synthesis from choline and acetyl-CoA Choline acetyltransferase Choline transporter Vesicular acetylcholine transporter Acetylcholinesterase Calcium-dependent exocytosis Recycling of synaptic vesicles Clathrin-mediated endocytosis Safety factor at the neuromuscular junction Neuromuscular junction fatigue T tubules Excitation-contraction coupling Hemicholinium Vesamicol Botulinum toxin Curare and d-tubocurarine Anticholinesterase drugs Neostigmine and physostigmine Myasthenia gravis Anti-acetylcholine receptor antibodies

Health & Medicine◦
Related topics:
Myasthenia Gravis• medical-physiology• Medical Education•
Neuromuscular Junction Dr Faiza MBBS (Best Graduate, AIMC Lahore) FCPS Physiology, MHPE (Riphah Int University, Islamabad) ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan)
Neuromuscular Junction • Junction between a motor nerve ending and a skeletal muscle fiber • Skeletal muscles are supplied by • Large, myelinated motor nerve fiber • Arising from the anterior horn of the spinal cord • Each motor nerve branches and supplies several muscle fibers • Most skeletal muscle fibers have only one neuromuscular junction
Motor End Plate • Terminal branches of the motor axon invaginate into the muscle surface • Nerve endings remain outside the muscle cell membrane • The complete junctional structure is called the motor end plate
Motor End Plate • The invaginated muscle membrane forms the synaptic gutter • The space between nerve and muscle is the synaptic cleft • Synaptic cleft width is approximately 20-30 nm
Subneural/Junctional Clefts • Numerous small folds on postsynaptic membrane • Increase the surface area of the muscle membrane
Subneural/Junctional Clefts • Nicotinic acetylcholine receptors are concentrated near the openings of the folds • Voltage-gated sodium channels are present deeper within the folds
Presynaptic Nerve Terminal • Contains numerous synaptic vesicles filled with acetylcholine • A single motor end plate contains about 300,000 vesicles • Each vesicle contains approximately 10,000 acetylcholine molecules
Presynaptic Nerve Terminal • Mitochondria provide ATP for acetylcholine synthesis • Voltage-gated calcium channels are present near release sites • Dense bars organize vesicle docking and transmitter release
Acetylcholine Receptor • Neuromuscular junction contains nicotinic acetylcholine receptors • Fetal Ach receptor contains: • Two alpha subunits • One beta subunit • One delta subunit • One gamma subunit • In adults, the epsilon subunit replaces the gamma subunit
Acetylcholine Receptor • Two acetylcholine molecules must bind to open the channel
Acetylcholine-Gated Channel • Receptor acts as a ligand-gated cation channel • Permits passage of: • Sodium • Potassium • Small amounts of calcium • Chloride cannot pass through the channel • Sodium influx is much greater than potassium efflux • Net inward positive current depolarizes the muscle membrane
End Plate Potential • May increase membrane voltage by 50-75 mV • It is a graded local potential • It is not an all-or-none response Acetylcholine opens nicotinic receptor channels Sodium enters the muscle fiber Local depolarizatio n develops at the motor end plate Local depolarizatio n = end plate potential
Generation of Muscle Action Potential Ach binds to ligand gated cation channels End plate potential Opening of voltage-gated sodium channels Sodium influx Rapid depolarization At Threshold - Muscle action potential Muscle AP spreads along the sarcolemma Initiates skeletal muscle contraction
14 Acetylcholine • Synthesized in the nerve terminal from choline and acetyl-CoA by the enzyme choline acetyltransferase (ChAT). • Choline Transport: Choline is brought into the terminal from the extracellular space via a Na⁺- dependent choline transporter (CHT). • Once synthesized, ACh is moved into small, clear synaptic vesicles by a vesicle-associated transporter (VAT). • Acetylcholinesterase quickly breaks down into Ach choline and acetate in the synaptic cleft. • Exocytosis: Upon Calcium influx via voltage gated Ca channels, that open upon action potential
15 • Hemicholinium: • Blocks the Na⁺-dependent choline transporter (CHT), preventing choline from entering the nerve terminal. • Vesamicol: • Blocks the vesicle-associated transporter (VAT), preventing ACh from being packaged into synaptic vesicles. • Botulinum Toxin: • Disrupts SNAPs and VAMPs, preventing the Ca²⁺- dependent release of ACh into the synaptic cleft.
16 • Curare e.g. d-tubocurarine • Reduces end plate potential by blocking nicotinic receptors • Decreasing NMJ transmission • Toxin Mimicry: • Muscarine (from toxic toadstools) mimics ACh at smooth muscles/glands; • Methacholine, carbachol, Nicotine mimics ACh at sympathetic ganglia and skeletal muscle. • Anticholinesterase Drugs • Neostigmine and physostigmine inhibit acetylcholinesterase • Neuromuscular transmission becomes prolonged • Severe toxicity may cause laryngeal spasm and respiratory failure
Recycling of Synaptic Vesicles • Vesicle membrane becomes part of the presynaptic membrane after exocytosis • Coated pits form within a few seconds • Clathrin helps recover the vesicle membrane • New vesicles are formed by endocytosis • Acetylcholine is transported into the recycled vesicles • Vesicles become ready for another cycle of release
Safety Factor at the Neuromuscular Junction • A normal nerve impulse produces an end plate potential much greater than threshold (3x stronger)
Fatigue of the Neuromuscular Junction • Very rapid stimulation (100 impulses per second) can reduce the number of available acetylcholine vesicles • End plate potential may fall below threshold • Some nerve impulses may fail to generate muscle action potentials • Junctional fatigue occurs mainly during extreme muscle activity
Role of T Tubules • Skeletal muscle fibers have a large diameter • Surface action potentials cannot directly reach deep myofibrils • Transverse tubules carry action potentials into the muscle fiber • Tubules are inward extensions of the sarcolemma • They bring electrical activity close to the sarcoplasmic reticulum
Transmission Across Neuromuscular Junction 1. Action potential in a motor neuron is propagated to the terminal button. 2. Opening of voltage-gated Ca2+ channels and the subsequent entry of Ca2+ into the terminal button. 3. Ca2+ triggers the release of acetylcholine (ACh) by exocytosis from a portion of the vesicles.
Transmission Across Neuromuscular Junction 4. ACh binds with receptor-channels specific for it on the motor end plate of the muscle cell membrane. 5. Opening of these nonspecific cation channels, leading to a relatively large movement of Na+ into the muscle cell compared to a smaller movement of K+ outward. 6. End-plate potential that travels to adjacent membrane.
Transmission Across Neuromuscular Junction 7. Local current flow opens voltage- gated Na+ channels in the adjacent membrane. 8. Resultant Na+ entry reduces the potential to threshold, initiating an action potential, which is propagated throughout the muscle fiber. 9. ACh is subsequently destroyed by acetylcholinesterasein synaptic cleft, terminating the muscle cell’s response.
• Muscle action potential travels along the sarcolemma • It enters the muscle fiber through T tubules • T-tubule depolarization triggers calcium release • Calcium is released from the sarcoplasmic reticulum • Calcium interacts with contractile proteins • Muscle contraction follows • This sequence is called excitation- contraction coupling Excitation Contraction Coupling
Clinical Case Scenario – Myasthenia Gravis • A 28-year-old woman presents with complaints of drooping eyelids and double vision that worsen as the day progresses. She also reports difficulty chewing and speaking, especially after prolonged conversations. Her symptoms improve after rest. On examination, she has bilateral ptosis, mild facial muscle weakness, and normal deep tendon reflexes. Muscle strength declines with repetitive movements. • There is no sensory deficit. A Tensilon test produces a brief improvement in muscle strength. Blood tests reveal anti- acetylcholine receptor antibodies. A chest CT shows an enlarged thymus.
Questions: • What is the most likely diagnosis? • What is the underlying pathophysiology? • What pharmacological and surgical treatments are appropriate? • What other autoimmune diseases should be screened for in this patient?
Myasthenia Gravis • Chronic autoimmune disease causing skeletal muscle weakness • Affects 25–125 per million, bimodal peak: • Women in 20s, men in 60s
Pathophysiology Caused by autoantibodies against nicotinic ACh receptors Destruction & Endocytosis of receptor complexes Impaired neuromuscular transmission Fatigue worsens with repetitive activity Improves with rest
Myasthenia Gravis Clinical Types 1.Ocular MG – extraocular muscle weakness 2.Generalized MG – widespread skeletal muscle weakness •In severe cases → diaphragm weakness → respiratory failure Diagnosis Eelectromyography: •Shows decremental response with repetitive stimulation •Detection of anti-AChR antibodies •Tensilon (edrophonium) test may show temporary improvement Histology • Flattened, widened, or absent synaptic clefts • 70–90% loss of ACh receptors at endplate Associated Conditions •Increased risk of autoimmune diseases: • SLE, RA, polymyositis •~30% have a family history of autoimmune disorders •Often associated with thymic hyperplasia or thymoma (10–15%)
Treatment • Acetylcholinesterase inhibitors • e.g., neostigmine, pyridostigmine • Immunosuppressants: • Prednisone, azathioprine, cyclosporine • Thymectomy: • Indicated if thymoma present • Also beneficial in non-thymoma cases (remission in ~35%) • Plasmapheresis or IVIG in crisis situations
Lambert-Eaton Myasthenic Syndrome (LEMS) Autoimmune destruction of presynaptic voltage-gated Ca²⁺ channels ↓ Ca²⁺ influx ACh → ↓ release at neuromuscular junction Leads to muscle weakness, especially in proximal lower limbs Weakness reduces with repetition
Lambert-Eaton Myasthenic Syndrome Adult-onset, equal in males and females • Weakness improves with repetitive stimulation • Common symptoms: • Waddling gait • Difficulty rising or lifting arms • No significant ocular involvement (unlike MG) Associated Conditions • 40% linked to small cell lung cancer (SCLC) • Also associated with other malignancies • Can mimic effects of aminoglycoside toxicity
Treatment • Treat underlying cancer if present • Immunotherapy: • Prednisone, IVIG, Pplasmapheresis • Aminopyridines: • Enhance ACh release by blocking K⁺ channels • AChE inhibitors: • Less effective than in MG
Dr Faiza, FCPS Physiology Thank You References: • Guyton, A. C., & Hall, J. E. (2021). Textbook of Medical Physiology (15th ed., Chapter 7: Excitation of Skeletal Muscle: Neuromuscular Transmission and Excitation Contraction Coupling ). Philadelphia, PA: Elsevier. • Barrett, K. E., Barman, S. M., Brooks, H. L., & Yuan, J. X.-J. (2019). Ganong’s Review of Medical Physiology (26th ed., Chapter 5: Excitable Tissue: Muscle). New York, NY: McGraw-Hill Education. • Sherwood, L. (2015). Human Physiology: From Cells to Systems (9th ed., Chapter 7: Excitable Tissue:Muscle). Boston, MA: Cengage Learning.